Liver histopathological features of chronic HBV carriers and inactive HBsAg carriers.
- Author:
Hui-min FAN
1
;
Zhan YANG
;
Chun-lan ZHANG
;
Wen-li LI
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Carrier State; pathology; virology; Child; Female; Hepatitis B Surface Antigens; blood; Hepatitis B virus; Hepatitis B, Chronic; pathology; virology; Humans; Liver; pathology; Male; Middle Aged; Young Adult
- From: Chinese Journal of Hepatology 2007;15(5):334-337
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the liver histopathological features of chronic HBV carriers and inactive HBsAg carriers.
METHODSLiver biopsies were performed on 189 chronic HBV carriers and 30 inactive HBsAg carriers (219 cases in total). All of them had a normal serum ALT value; they were then followed-up for more than 6 months. HBsAg and HBcAg were detected by immunohistochemistry. The circulating HBV DNA loads and serologic markers of HBV were examined at the same time. Grades of liver necrosis/inflammation and fibrosis were compared between the patients regarding their HBV DNA positivity or negativity. The relationships between the HBeAg positivity and degrees of liver histological changes were evaluated. The grades of liver necrosis/inflammation and fibrosis were compared between three age groups: younger than 18 years, 18-40, and older than 40 years.
RESULTSTwo hundred eight carriers of the total 219 (95.0%) had histological liver changes. Fifty percent (104/208) of them had mild histological changes (G0-1/S0-1), while more severe changes (G3-4 and/or S3-4) were found in 18 out of the 208. There were no significant differences in the grades of liver necrosis/inflammation and fibrosis between the chronic HBV carriers and the inactive HBsAg carriers. Among the serologic HBV DNA positive carriers, hepatic fibrosis was more severe in the HBeAg negative group than in the positive group (chi2 = 9.551, P = 0.008), but no differences of the necrosis/inflammation grades were seen between the two groups. The rate of severe fibrosis (S3-4) was 21.1% in those carriers older than 40 years but was 7.7% in patients younger than 18 years. However, no statistically significant differences in degrees of liver inflammation and fibrosis were found among the three age groups. HBcAg positive rate was 100% in the liver tissues of all the chronic HBV carriers, but only in 33.3% in the inactive HBsAg carriers.
CONCLUSIONSThe majority of our HBV carriers have liver inflammation and fibrosis. More severe histological changes were found in 8.65% of them. Liver fibrosis existed in the carriers with negative HBeAg and in those older than 40 years. HBcAg was found in hepatic tissues while their serological HBV DNA was negative.